In order to adjust to low oxygen concentrations in the BMM to facilitate dormancy and self-renewal of CML LSC, the STAT5/HIF-2α/CITED pathway is activated. The gene discussed is EPAS1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.